histocompatible bone marrow transplantation ( bmt ) is the treatment of choice for pediatric patients with second remission acute lymphoblastic leukemia or acute myelogenous leukemia ( aml ) and has been successfully used to treat patients with first remission aml and stable-phase chronic myelogenous leukemia .
C0005961
bone marrow transplantation
C0087111
treat